Xiaoting Zhang

2.3k citations
42 papers · 1.1k indexed · h-index 19
Topics
RNA modifications and cancer (11 papers)RNA and protein synthesis mechanisms (6 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Xiaoting Zhang

36 papers receiving 1.1k citations

Peers

Xiaoting Zhang
Comparison fields: 5 of 104
  • Molecular Biology 770
  • Cancer Research 261
  • Infectious Diseases 140
  • Epidemiology 119
  • Oncology 84
Replace Huifang Hao with:
Huifang Hao China
Sheng Gu United States
Megan Garland United States
Dasheng Wang United States
Chengpeng Fan China
Rinku Dutta United States
John S. Choy United States
Pengfei Fang China
Xinqi Liu China
Xiaoting Zhang relative to Huifang Hao China Huifang Hao's profile →
Citations per field
00.5×1.5×2.1×
Huifang Hao · 1×
Citations per year

Countries citing papers authored by Xiaoting Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaoting Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Zhang more than expected).

Fields of papers citing papers by Xiaoting Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoting Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Zhang. The network helps show where Xiaoting Zhang may publish in the future.

Co-authorship network of co-authors of Xiaoting Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoting Zhang. A scholar is included among the top collaborators of Xiaoting Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoting Zhang. Xiaoting Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 2
5 26
6 0
7 20
8 1
9 5
10 3
11 18
12 11
13 8
14 17
15 62
16 18
17 204
18 1
19 30
20 68

About Xiaoting Zhang

Xiaoting Zhang is a scholar working on Biochemistry, Molecular Biology and Cancer Research, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), RNA and protein synthesis mechanisms (6 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (261 citations), Molecular Biology (770 citations) and Infectious Diseases (140 citations). Xiaoting Zhang has collaborated with scholars based in China, United States and Montenegro. Frequent co-authors include W. Scott Moye‐Rowley, Chengqi Yi, Haowei Meng, June Liu, Sean T. Coleman, Dominique Sanglard, Xushen Xiong, Mingchang Zhang, Xizhan Xu and Jiabin Cai. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026